The use of ribavirin for the treatment of RSV infection is
controversial. Nevertheless, some experts consider ribavirin
for the treatment of severe forms of LRT disease in SOT
recipients [17]. Aerosolized ribavirin can be administered as
2 g for 2 h every 8 h or as 6 g over 18 h/day for 7–10 days.
Appropriate precautions should be taken to avoid environ